Pixelgen Technologies Unveils Molecular Pixelation for Spatial Analysis of Cell Surface Proteins at AGBT General Meeting
STOCKHOLM, Feb. 3, 2023 /PRNewswire/ -- Pixelgen Technologies, the single cell spatial proteomics company, announced today that it will unveil its groundbreaking Molecular Pixelation technology for spatial analysis of cell surface proteins in 3D at the Advances in Genome Biology and Technology General Meeting in Hollywood, Florida, Feb. 6-9.
"We're excited and honored to attend AGBT and to present details of our Molecular Pixelation technology for the first time publicly since we emerged from stealth in December 2022," said Pixelgen CEO Simon Fredriksson, Ph.D. "We aim to close the gaps in understanding cellular activity by offering a view of cell surface proteins and their spatial inter-relationships far exceeding existing technologies' capabilities. We believe our Molecular Pixelation technology will become an essential tool for spatial biology in cells and tissues."
The company will provide details and data from its Molecular Pixelation technology during a poster presentation and a sponsored breakfast. The poster, titled "Spatial analyses of the single immune cell surface proteome by Molecular Pixelation," will be presented by Fredriksson on Tuesday, Feb. 7, from 1:30 p.m. to 3:30 p.m. in the Regency Ballroom. The breakfast will take place on Feb. 8 from 7:30-9 a.m. at the South Palm Court. During the breakfast, attendees will have the chance to learn more about how Molecular Pixelation enables deeper single cell phenotyping.
Details of Pixelgen's Molecular Pixelation technology come as the company prepares for a full commercial product launch later this year. To learn more about Pixelgen's AGBT participation and to enter to win a free kit as part of our dedicated conference offering, please visit our Pixelgen AGBT website here.
Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by mapping cell surface proteins and their spatial inter-relationships. The company has developed Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins, to gain novel insights into cellular activity that will advance better medicines and diagnostics. Pixelgen is headquartered in Stockholm, Sweden.
+46 762-69 68 46
View original content to download multimedia:https://www.prnewswire.com/news-releases/pixelgen-technologies-unveils-molecular-pixelation-for-spatial-analysis-of-cell-surface-proteins-at-agbt-general-meeting-301738115.html
SOURCE Pixelgen Technologies
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
Latest company news
Sectra's year-end report 2022/2023: Historic quarter to end another successful fiscal year--higher dividend proposed
Sobi to present new data at the 2023 EHA congress
Medivir has completed the dose escalation part (phase 1b) of the 1b/2a study in HCC and focuses on the combination of fostrox and Lenvima